Synergia Medical is developing a revolutionary neurostimulation technology. In this technology, wires are replaced by fiber optics and photovoltaic cells convert optical energy into electrical impulses. Visit our website for additional information
Location: Belgium, Walloon Brabant, Corbais
Employees: 11-50
Total raised: $10.04M
Founded date: 2013
Investors 3
| Date | Name | Website |
| - | Newton Bio... | newtonbioc... |
| 13.10.2022 | Le Groupe ... | sriw.be |
| - | SFPIM | sfpim.be |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.02.2018 | Series A | $10.04M | - |
Mentions in press and media 5
| Date | Title | Description |
| 24.06.2024 | SYNERGIA MEDICAL NOMINEE FOR PRESTIGIOUS 2024 INTERNATIONAL PRIX GALIEN FOR ITS OPTOELECTRONIC NEUROSTIMULATOR | BRUSSELS, BELGIUM, June 24, 2024 /EINPresswire.com/ -- Synergia Medical, a preclinical medical device company that has developed NAO.VNS, the first optoelectronic neurostimulator for the treatment of drug-resistant epilepsy through Vagus Ne... |
| 29.04.2024 | SYNERGIA MEDICAL OBTAINS BELGIUM HEALTH AUTHORITY APPROVAL TO START FIRST IN HUMAN CLINICAL STUDY | Synergia Medical to start NAO.VNS FIH study, the first quartz optoelectronic neurostimulator for the treatment of drug-resistant epilepsy. This go ahead from the Belgium health authority is a major milestone in our development of the world’... |
| 17.03.2023 | SYNERGIA MEDICAL WINS PRESTIGIOUS PRIX GALIEN IN BELGIUM FOR ITS OPTOELECTRONIC NEUROSTIMULATOR | Synergia Medical wins Belgium Prix Galien 2023 promising device award Synergia Medical is pleased to announce that they have been awarded the Prix Galien 2023 in Belgium for promising medical devices. The recognition by the jury that our de... |
| 18.01.2023 | SYNERGIA MEDICAL INCREASES SERIES B FUNDING TO €12.8 MILLION WITH AN ADDITIONAL €3.8 MILLION | Synergia Medical announced the completion of an additional €3.8 million of Series B funding, allowing the preparation for FIH clinical trials planned for 2024 I believe that Synergia Medical’s epilepsy treatment has huge potential and I am ... |
| 28.11.2022 | SYNERGIA MEDICAL STRENGTHENS ITS MANAGEMENT TEAM WITH THE APPOINTMENT OF DAN SCHERRER AS COO | Synergia Medical announced today the appointment of Dan Scherrer as Chief Operating Officer who brings over 20 years of experience in the medical device field. We are delighted to welcome Dan to the management team. His wide and valuable ex... |